Lee YJ, Wang H, Starrett GJ, Phuong V, Jameson SC, Hogquist KA
Mearns ES, Saulsberry WJ, White CM et al (2015) Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta-analysis
Novo Nordisk argues that the benefits of taking Ozempic outweigh any risks associated with taking the drug and dismisses claims related to severe side effects, such as gastroparesis, intestinal obstruction, and gallbladder issues
It is a drug part of the glucagon-like-peptide 1 receptor antagonists, or GLP-1 receptor antagonist family, that when specifically used for treating weight loss, acts on GLP-1 receptors in the brain, on top of the liver, pancreas, and stomach
Strains like Lactobacillus acidophilus and Bifidobacterium lactis have been shown to support intestinal barrier function, promote natural GLP-1 secretion, and may modulate autoimmune responses